SCHEMBL8842471

SCHEMBL8842471

C=C(OC)c1ccc(OC)cc1[N+](=O)[O-]

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.53
AKR1C3 P42330 4/20 0.50
AKR1C2 P52895 4/20 0.50
RAB9A P51151 4/20 0.49
NPC1 O15118 3/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 6/20 0.49
MAPK1 P28482 3/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 6/20 0.49
LMNA P02545 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
AKR1B10 O60218 1/20 0.47
AKR1B1 P15121 1/20 0.47
AKR1C4 P17516 1/20 0.47
AKR1C1 Q04828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29559880 0.86 ALDH1A1 (0.50) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL12326835 0.86 ALDH1A1 (0.50) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL1571262 0.83 AKR1C3 (0.54) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL3885239 0.82 AKR1C3 (0.51) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL8842593 0.81 HPGD (0.51) RAB9ANPC1CYP1A2CYP3A4CYP2C19
SCHEMBL147187 0.81 AKR1C3 (0.63) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL1632528 0.81 ALDH1A1 (0.57) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL22749356 0.80 AKR1C3 (0.52) KDM4EAKR1C3AKR1C2RAB9ANPC1
Hydrochloric Acid SCHEMBL11773334 0.79 AKR1C3 (0.61) KDM4EAKR1C3AKR1C2RAB9ANPC1
SCHEMBL1567614 0.79 NPC1 (0.53) KDM4EAKR1C3AKR1C2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5688803-A BRAIN DISORDERS; PSYCHOLOGICAL DISORDERS HOFFMANN-LA ROCHE INC. (US) 1997-11-18 US disclosed